{"id":5203,"date":"2022-01-23T23:14:48","date_gmt":"2022-01-23T23:14:48","guid":{"rendered":"https:\/\/www.beamed.co.th\/?p=5203"},"modified":"2022-01-23T23:14:48","modified_gmt":"2022-01-23T23:14:48","slug":"sofwave-awarded-elle-magazines-2021-future-of-beauty-awards","status":"publish","type":"post","link":"https:\/\/www.beamed.co.th\/en\/sofwave-awarded-elle-magazines-2021-future-of-beauty-awards\/","title":{"rendered":"Sofwave\u2122 Awarded ELLE Magazine\u2019s 2021 Future of Beauty Awards!"},"content":{"rendered":"<h3><span style=\"font-family: Helvetica;\"><strong>TUSTIN, Calif.,\u00a0Dec. XX, 2021\u00a0\/PRNewswire\/ \u2014\u00a0Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, has been honored with the Elle Magazine\u2019s \u201c2021 Future of Beauty Awards\u201d and named Sofwave as one of the best in the In-Office Skin Treatment Category.<\/strong><\/span><\/h3>\n<p><span style=\"font-family: Helvetica;\">Sofwave Medical Ltd, an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, has been honored with the ELLE Magazine\u2019s \u201c2021 Future of Beauty Awards\u201d and named Sofwave as one of the best in the In-Office Skin Treatment Category.<\/span><\/p>\n<p><span style=\"font-family: Helvetica;\">Sofwave<sup>TM<\/sup>\u00a0is the latest technology to revitalize the skin through innovative stimulation of the production of new collagen. Sofwave<sup>TM<\/sup>\u00a0Synchronous Ultrasound Parallel Beam Technology is FDA cleared for lifting the eyebrow, submental, and neck and reducing fine lines and wrinkles.<\/span><\/p>\n<p><span style=\"font-family: Helvetica;\">\u201cWe are honored to be recognized and featured in the latest edition of ELLE,\u201d said Sofwave\u2019s Chief Digital Officer,\u00a0Lina Omari. \u201cThis highly coveted industry award is further validation that Sofwave\u2019s breakthrough technology delivers exceptional results to physicians and their patients.<\/span><\/p>\n<p><span style=\"font-family: Helvetica;\">\u201cELLE Magazine\u2019s prestigious industry award recognizing 2021\u2019s most exciting innovations in skin treatments showcases Sofwave Medical\u2019s pioneering advancement in energy-based technology,\u201d said Sofwave\u2019s Chief Executive Officer Louis Scafuri. \u201cThe\u00a0<a href=\"https:\/\/sofwave.com\/patients\/about-us\/\">SUPERB<sup>TM\u00a0<\/sup><\/a>\u00a0(Synchronous Ultrasound Parallel Beam) is a novel, industry-leading technology offering practitioners a non-invasive treatment for high demand lifting treatments of face and neck. We will continue to develop innovative products that advance the medical aesthetics industry and meet the needs of our customers and the needs of their patients.\u201d<\/span><\/p>\n<p><span style=\"font-family: Helvetica;\"><strong>About<br \/>\n<\/strong>Sofwave Medical Ltd.\u00a0has implemented an innovative approach to wrinkle reduction and lifting using proprietary breakthrough technology. Synchronous Ultrasound Parallel Beam technology is FDA-cleared to improve facial lines and wrinkles, lifting the eyebrow, and lifting lax submental tissue (beneath the chin) and neck tissue providing physicians with smart yet simple, effective, and safe aesthetic solutions for their patients.<\/span><\/p>\n<p><span style=\"font-family: Helvetica;\">https:\/\/www.prnewswire.com\/news-releases\/sofwave-awarded-elle-magazines-2021-future-of-beauty-awards-301443079.html?tc=eml_cleartime<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>TUSTIN, Calif.,\u00a0Dec. XX, 2021\u00a0\/PRNewswire\/ \u2014\u00a0Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, has been honored with the Elle Magazine\u2019s \u201c2021 Future of Beauty Awards\u201d and named Sofwave as one of the best in the In-Office Skin Treatment Category. Sofwave Medical Ltd, an emerging leader in energy-based<\/p>\n","protected":false},"author":1,"featured_media":4822,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-5203","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/posts\/5203","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/comments?post=5203"}],"version-history":[{"count":0,"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/posts\/5203\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/media\/4822"}],"wp:attachment":[{"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/media?parent=5203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/categories?post=5203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.beamed.co.th\/en\/wp-json\/wp\/v2\/tags?post=5203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}